“Efficacy of Secukinumab in Patients With Mild to Moderate Psoriasis: A Pooled Analysis of 6 Phase 3 Studies ”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s231. https://doi.org/10.25251/skin.7.supp.231.